• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NT-proBNP 介导成纤维细胞生长因子 23 与 2 型糖尿病患者全因死亡率的相关性。

NT-proBNP Mediates the Association Between FGF23 and All-Cause Mortality in Individuals With Type 2 Diabetes.

机构信息

Department of Internal Medicine, Division of Nephrology University Medical Center Groningen, University of Groningen Groningen The Netherlands.

Department of Internal Medicine, Division of Endocrinology University Medical Center Groningen, University of Groningen Groningen The Netherlands.

出版信息

J Am Heart Assoc. 2023 Dec 5;12(23):e031873. doi: 10.1161/JAHA.123.031873. Epub 2023 Nov 28.

DOI:10.1161/JAHA.123.031873
PMID:38014662
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727346/
Abstract

BACKGROUND

FGF23 (fibroblast growth factor 23) is associated with a higher mortality risk in type 2 diabetes, but the mechanism is unclear. We aimed to study whether NT-proBNP (N-terminal pro-brain natriuretic peptide) mediates the association between FGF23 and mortality.

METHODS AND RESULTS

We analyzed C-terminal FGF23 and NT-proBNP levels in 399 patients with type 2 diabetes. Cox regression analyses were performed, followed by mediation analyses using Structural Equation Modeling. During follow-up of 9.2 [7.6-11.3] years, 117 individuals died. FGF23 was associated with all-cause mortality, independent of potential confounders (fully adjusted hazard ratio [HR], 2.32 [95% CI, 1.21-4.43], =0.01). The association was lost upon further adjustment for NT-proBNP (HR, 1.84; 95% CI, 0.91-3.73). NT-proBNP accounted for 26% of the mediation effect between FGF23 and all-cause mortality.

CONCLUSIONS

These findings suggest that a higher FGF23 level is associated with increased mortality in individuals with type 2 diabetes through an effect on volume homeostasis.

摘要

背景

成纤维细胞生长因子 23(fibroblast growth factor 23,FGF23)与 2 型糖尿病患者的死亡率升高相关,但具体机制尚不清楚。我们旨在研究 N 端脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)是否介导 FGF23 与死亡率之间的关联。

方法和结果

我们分析了 399 例 2 型糖尿病患者的 C 端 FGF23 和 NT-proBNP 水平。进行了 Cox 回归分析,随后使用结构方程模型进行中介分析。在 9.2[7.6-11.3]年的随访期间,有 117 人死亡。FGF23 与全因死亡率相关,独立于潜在混杂因素(完全调整后的危险比 [HR],2.32[95%CI,1.21-4.43],=0.01)。进一步调整 NT-proBNP 后,该关联消失(HR,1.84;95%CI,0.91-3.73)。NT-proBNP 解释了 FGF23 与全因死亡率之间 26%的中介效应。

结论

这些发现表明,较高的 FGF23 水平与 2 型糖尿病患者的死亡率升高相关,这是通过对容量平衡的影响实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/10727346/5217aa9a1bfb/JAH3-12-e031873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/10727346/5217aa9a1bfb/JAH3-12-e031873-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2be5/10727346/5217aa9a1bfb/JAH3-12-e031873-g001.jpg

相似文献

1
NT-proBNP Mediates the Association Between FGF23 and All-Cause Mortality in Individuals With Type 2 Diabetes.NT-proBNP 介导成纤维细胞生长因子 23 与 2 型糖尿病患者全因死亡率的相关性。
J Am Heart Assoc. 2023 Dec 5;12(23):e031873. doi: 10.1161/JAHA.123.031873. Epub 2023 Nov 28.
2
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease.应激性高血糖比值与N末端B型脑钠肽前体预测多支冠状动脉疾病糖尿病患者全因死亡率的相对及联合能力。
Cardiovasc Diabetol. 2024 Mar 11;23(1):93. doi: 10.1186/s12933-024-02186-2.
3
Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.成纤维细胞生长因子 23 与肾移植后心血管死亡率。
Clin J Am Soc Nephrol. 2013 Nov;8(11):1968-78. doi: 10.2215/CJN.01880213. Epub 2013 Aug 8.
4
Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.成纤维细胞生长因子 23 作为心血管风险预测因子在慢性肾脏病中的作用被 ProBNP 调整削弱。
Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26.
5
Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.常规测量心肌肌钙蛋白 I 和 N 末端 B 型利钠肽原作为血液透析患者死亡率的预测指标。
ESC Heart Fail. 2022 Apr;9(2):1138-1151. doi: 10.1002/ehf2.13784. Epub 2022 Jan 13.
6
N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.N 端脑利钠肽前体水平在评估老年伴有心房颤动的中国患者全因死亡率方面具有独立的附加能力。
BMC Geriatr. 2019 Feb 28;19(1):56. doi: 10.1186/s12877-019-1051-0.
7
Pretransplant NT-proBNP, Dialysis Vintage, and Posttransplant Mortality in Kidney Transplant Recipients.移植前 NT-proBNP、透析年限和肾移植受者移植后死亡率。
Transplantation. 2020 Oct;104(10):2158-2165. doi: 10.1097/TP.0000000000003125.
8
[Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].N末端B型利钠肽对射血分数保留的心力衰竭患者全因死亡率的预后价值
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):875-881. doi: 10.3760/cma.j.issn.0253-3758.2019.11.005.
9
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.总 NT-proBNP,一种与复发性心房颤动相关的新型生物标志物。
BMC Cardiovasc Disord. 2021 Nov 19;21(1):553. doi: 10.1186/s12872-021-02358-y.
10
Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.比较利钠肽作为 1 型糖尿病患者全因死亡率及心血管和肾脏并发症的风险标志物。
Diabetes Care. 2021 Feb;44(2):595-603. doi: 10.2337/dc20-2107. Epub 2020 Dec 15.

本文引用的文献

1
Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium.一般人群中心力衰竭的糖尿病相关危险因素和中介因素的差异:来自 MORGAM/BiomarCaRE 联盟的研究结果。
Cardiovasc Diabetol. 2021 Sep 28;20(1):195. doi: 10.1186/s12933-021-01378-4.
2
Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure.急性心力衰竭患者中完整成纤维细胞生长因子23水平与预后预测
Sci Rep. 2021 Jul 30;11(1):15507. doi: 10.1038/s41598-021-94780-7.
3
Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.
成纤维细胞生长因子 23 与 2 型糖尿病不良临床结局:苦乐参半的交响曲。
Curr Diab Rep. 2020 Aug 28;20(10):50. doi: 10.1007/s11892-020-01335-7.
4
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.成纤维细胞生长因子 23 与普通人群中新发的慢性肾脏病:肾脏和血管终末期疾病预防(PREVEND)研究。
Nephrol Dial Transplant. 2021 Jan 1;36(1):121-128. doi: 10.1093/ndt/gfz266.
5
Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure: A Population Study.糖尿病是心力衰竭发展的独立预测因素:一项人群研究。
Mayo Clin Proc. 2020 Jan;95(1):124-133. doi: 10.1016/j.mayocp.2019.07.008.
6
Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research.基于时间事件结局的中介分析:在医疗保健研究中的应用和报告综述。
BMC Med Res Methodol. 2018 Oct 29;18(1):118. doi: 10.1186/s12874-018-0578-7.
7
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.成纤维细胞生长因子 23 与新出现和恶化心力衰竭患者的容量超负荷、治疗优化不良和预后相关的特征有关。
Int J Cardiol. 2018 Feb 15;253:84-90. doi: 10.1016/j.ijcard.2017.10.010.
8
Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT).糖尿病与生活方式队列特温特研究(DIALECT)中药物和营养性心血管风险管理的综合评估:血压控制
Nutrients. 2017 Jul 6;9(7):709. doi: 10.3390/nu9070709.
9
Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.成纤维细胞生长因子23对动脉高血压和糖尿病肾病容量干预的反应。
Medicine (Baltimore). 2016 Nov;95(46):e5003. doi: 10.1097/MD.0000000000005003.
10
FGF23 regulates renal sodium handling and blood pressure.成纤维细胞生长因子 23 调节肾脏钠处理和血压。
EMBO Mol Med. 2014 Jun;6(6):744-59. doi: 10.1002/emmm.201303716. Epub 2014 Apr 6.